Accelerating timelines vital to securing slice of biosimilars market, KBI
By Dan Stanton+, 24-Aug-2016
Accelerated development gives biosimilars an upper hand in gaining market share, CMO KBI Biopharma told delegates in Korea yesterday.
http://www.biopharma-reporter.com/Upstream-Processing/Expediting-timelines-key-to-securing-slice-of-biosimilars-market-KBI